Bilirubin, a Cardiometabolic Signaling Molecule

被引：94

作者：

Hinds, Terry D., Jr. ^{[1
]}

Stec, David E. ^{[2
]}

机构：

[1] Univ Toledo, Dept Physiol & Pharmacol, Coll Med, 2801 W Bancroft St, Toledo, OH 43606 USA

[2] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Mississippi Ctr Obes Res, Jackson, MS 39216 USA

来源：

HYPERTENSION | 2018年 / 72卷 / 04期

关键词：

ACTIVATED RECEPTOR-ALPHA; HUMAN BILIVERDIN REDUCTASE; TYPE-2; DIABETES-MELLITUS; INCREASES INSULIN SENSITIVITY; II-DEPENDENT HYPERTENSION; SERUM BILIRUBIN; HEPATIC STEATOSIS; GILBERTS-SYNDROME; MODERATE HYPERBILIRUBINEMIA; CARDIOVASCULAR-DISEASE;

D O I：

10.1161/HYPERTENSIONAHA.118.11130

中图分类号：

R6 [外科学];

学科分类号：

100210 [外科学];

摘要：

[No abstract available]

引用

页码：788 / 795

页数：8

共 92 条

[41]

Serum bilirubin levels are lower in overweight asymptomatic middle-aged adults: An early indicator of metabolic syndrome? [J].

Jenko-Praznikar, Zala ;

Petelin, Ana ;

Jurdana, Mihaela ;

Ziberna, Lauro .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (07) :976-985

[42]

Fenofibrate Attenuates Malignant Hypertension by Suppression of the Renin-angiotensin System: A Study in Cyp1a1-Ren-2 Transgenic Rats [J].

Jichova, Sarka ;

Dolezelova, Sarka ;

Kopkan, Libor ;

Kompanowska-Jezierska, Elzbieta ;

Sadowski, Janusz ;

Cervenka, Ludek .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 352 (06) :618-630

[43]

Association between serum bilirubin and cardiovascular disease in an overweight high risk population from the SCOUT trial [J].

Jorgensen, M. E. ;

Torp-Pedersen, C. ;

Finer, N. ;

Caterson, I. ;

James, W. P. T. ;

Legler, U. F. ;

Andersson, C. .

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2014, 24 (06) :656-662

[44]

Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor α by phosphorylation of a dependent trans-activating domain [J].

Juge-Aubry, CE ;

Hammar, E ;

Siegrist-Kaiser, C ;

Pernin, A ;

Takeshita, A ;

Chin, WW ;

Burger, AG ;

Meier, CA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (15) :10505-10510

[45]

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial [J].

Keech, A ;

Simes, RJ ;

Barter, P ;

Best, J ;

Scott, R ;

Taskinen, MR ;

Forder, P ;

Pillai, A ;

Davis, T ;

Glasziou, P ;

Drury, P ;

Kesäniemi, YA ;

Sullivan, D ;

Hunt, D ;

Colman, P ;

d'Emden, M ;

Whiting, M ;

Ehnholm, C ;

Laakso, M .

LANCET, 2005, 366 (9500) :1849-1861

[46]

Mild hyperbilirubinaemia as an endogenous mitigator of overweight and obesity: Implications for improved metabolic health [J].

Khoei, Nazlisadat Seyed ;

Grindel, Annemarie ;

Wallner, Marlies ;

Moelzer, Christine ;

Doberer, Daniel ;

Marculescu, Rodrig ;

Bulmer, Andrew ;

Wagner, Karl-Heinz .

ATHEROSCLEROSIS, 2018, 269 :306-311

[47]

BILIRUBIN INHIBITS THE ACTIVATION OF SUPEROXIDE-PRODUCING NADPH OXIDASE IN A NEUTROPHIL CELL-FREE SYSTEM [J].

KWAK, JY ;

TAKESHIGE, K ;

CHEUNG, BS ;

MINAKAMI, S .

BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1076 (03) :369-373

[48]

Bilirubin decreases NOS2 expression via inhibition of NAD(P)H oxidase:: implications for protection against endotoxic shock in rats [J].

Lanone, S ;

Bloc, S ;

Foresti, R ;

Almolki, A ;

Taillé, C ;

Callebert, J ;

Conti, M ;

Goven, D ;

Aubier, M ;

Dureuil, B ;

El-Benna, J ;

Motterlini, R ;

Boczkowski, J .

FASEB JOURNAL, 2005, 19 (10) :1890-+

[49]

Peroxisome proliferator-activated receptor-α agonist, Wy 14 643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis [J].

Larter, Claire Z. ;

Yeh, Matthew M. ;

Van Rooyen, Derrick M. ;

Brooling, John ;

Ghatora, Kamaljit ;

Farrell, Geoffrey C. .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (02) :341-350

[50]

Lee SJ, 2017, STROKE, V48, P1154, DOI [10.1161/strokeaha.116.015083, 10.1161/STROKEAHA.116.015083]

← 1 2 3 4 5 6 7 8 9 10 →